Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST-1: Icatibant for Acute HAE Attacks
NCT00097695Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2004
- Primary completion
- Jul 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icatibant in hereditary angioedema (HAE), sponsored by Takeda. Started Dec 2004; status: completed.
02
Drugs
icatibant
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT00097695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097695.